SCHEMBL24249663

SCHEMBL24249663

CCNc1cc(C)c2ccccc2n1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.71
▸ SMN1; SMN2 Q16637 4/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ HPGD P15428 1/20 0.71
▸ KMT2A Q03164 7/20 0.61
▸ MEN1 O00255 5/20 0.61
▸ RAB9A P51151 3/20 0.56
▸ CYP1A2 P05177 1/20 0.55
▸ LMNA P02545 3/20 0.54
▸ MAPT P10636 6/20 0.52
▸ BACE1 P56817 1/20 0.51
▸ POLB P06746 1/20 0.50
▸ GAA P10253 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ LRRK2 Q5S007 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ HTT P42858 1/20 0.48
▸ PAX8 Q06710 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9314099 0.82 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL1187744 0.82 KDM4E (0.80) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL31098995 0.82 KDM4E (0.65) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL11712509 0.82 KDM4E (0.65) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL20867956 0.82 KDM4E (0.61) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL8694650 0.80 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL1577669 0.79 ALDH1A1 (0.63) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL8696930 0.78 TP53 (0.60) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL8697731 0.77 RAD52 (0.63) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL22545323 0.77 KDM4E (0.59) KDM4ESMN1; SMN2ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3954692-A1 METHOD FOR MODIFYING AMINO GROUP IN MOLECULE WITH OXAZOLINE QUATERNARY AMMONIUM SALT AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2022-02-16 — — EP disclosed
CN-1332942-C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD (CH) 2007-08-22 — — CN disclosed
CN-1703397-A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD (CH) 2005-11-30 — — CN disclosed
Send feedback